Patents by Inventor Karin Schreier

Karin Schreier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD25 BINDING MOLECULES FOR THE USE IN THE TREATMENT OF MANIFESTATIONS OF REJECTION IN TRANSPLANTATION
    Publication number: 20080286281
    Abstract: Administration of monoclonal antibodies specific for IL-2R to xenograft recipients, or long-term to immunosuppression-intolerant or non-compliant patients over a period of time beyond the very early phase of organ transplantation, prevents transplant rejection.
    Type: Application
    Filed: July 28, 2008
    Publication date: November 20, 2008
    Inventors: Gilles Feutren, Richard Kimberley Howell, Peter Marbach, Andrew Roberts, Max H. Schreier, Karin Schreier, Daniel Mark Schreier, Anja Bettina Schreier, Manfred Schulz
  • Use of CD25 binding molecules in the treatment of rheumatoid arthritis or skin diseases
    Publication number: 20020110558
    Abstract: Use of a CD25 binding molecule which comprises at least one antigen binding site comprising at least one domain which comprises in sequence, the hypervariable regions CDR1, CDR2 and CDR3; said CDR1 having the amino acid sequence Arg-Tyr-Trp-Met-His, said CDR2 having the amino acid sequence Ala-Ile-Tyr-Pro-Gly-Asn-Ser-Asp-Thr-Ser-Tyr-Asn-Gln-Lys-Phe-Glu-Gly, and said CDR3 having the amino acid sequence Asp-Tyr-Gly-Tyr-Tyr-Phe-Asp-Phe, in the treatment of rheumatoid arthritis or inflammatory or hyperproliferative skin diseases.
    Type: Application
    Filed: January 25, 2001
    Publication date: August 15, 2002
    Inventors: Peter Lloyd Amlot, Max H. Schreier, Karin Schreier
  • CD25 binding molecules for use in the treatment of manifestations of rejection in transplantation
    Publication number: 20010041179
    Abstract: Administration of monoclonal antibodies specific for IL-2R to xenograft recipients, or long-term to immunosuppression-intolerant or non-compliant patients over a period of time beyond the very early phase of organ transplantation, prevents transplant rejection.
    Type: Application
    Filed: May 22, 2001
    Publication date: November 15, 2001
    Inventors: Gilles Feutren, Richard Kimberley Howell, Peter Marbach, Andrew Roberts, Max H. Schreier, Karin Schreier, Daniel Mark Schreier, Anja Bettina Schreier, Manfred Schulz